Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D004827:Epilepsy / Q000139:chemically induced; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced; D014748:Vinca Alkaloids / Q000009:adverse effects / Q000627:therapeutic use*
D014748:Vinca Alkaloids